We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
32 hedge funds and large institutions have $13.9M invested in Zevra Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
5% less capital invested
Capital invested by funds: $14.6M → $13.9M (-$710K)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
16% less funds holding
Funds holding: 38 → 32 (-6)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
8
Closed
9
Calls
$49K
Puts
–
Net Calls
+$49K
Net Calls Change
+$84K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.2M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$40.8K |
| 3 |
ISB
Iowa State Bank
Urbandale,
Iowa
|
+$33K |
| 4 |
BlackRock
New York
|
+$29.9K |
| 5 |
RFN
RDA Financial Network
Akron,
Iowa
|
+$27.5K |
